HK1019603A1 - Taxane derivatives, the preparation thereof and formulations containing them - Google Patents

Taxane derivatives, the preparation thereof and formulations containing them

Info

Publication number
HK1019603A1
HK1019603A1 HK99104797A HK99104797A HK1019603A1 HK 1019603 A1 HK1019603 A1 HK 1019603A1 HK 99104797 A HK99104797 A HK 99104797A HK 99104797 A HK99104797 A HK 99104797A HK 1019603 A1 HK1019603 A1 HK 1019603A1
Authority
HK
Hong Kong
Prior art keywords
pct
deacetyl
derivatives
preparation
sec
Prior art date
Application number
HK99104797A
Other languages
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of HK1019603A1 publication Critical patent/HK1019603A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK99104797A 1996-05-10 1999-10-27 Taxane derivatives, the preparation thereof and formulations containing them HK1019603A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI000942A IT1283633B1 (it) 1996-05-10 1996-05-10 Derivati tassanici loro sintesi e formulazioni che li contengono
PCT/EP1997/002198 WO1997043291A1 (fr) 1996-05-10 1997-04-29 Derives de taxane, leur preparation et formulations les contenant

Publications (1)

Publication Number Publication Date
HK1019603A1 true HK1019603A1 (en) 2000-02-18

Family

ID=11374240

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99104797A HK1019603A1 (en) 1996-05-10 1999-10-27 Taxane derivatives, the preparation thereof and formulations containing them

Country Status (21)

Country Link
US (1) US5955489A (fr)
EP (1) EP0901492B1 (fr)
JP (1) JP3423002B2 (fr)
KR (1) KR100314382B1 (fr)
CN (1) CN1097055C (fr)
AT (1) ATE220680T1 (fr)
AU (1) AU715748B2 (fr)
CA (1) CA2253912C (fr)
CZ (1) CZ287489B6 (fr)
DE (1) DE69714040T2 (fr)
DK (1) DK0901492T3 (fr)
ES (1) ES2180985T3 (fr)
HK (1) HK1019603A1 (fr)
HU (1) HU224965B1 (fr)
IT (1) IT1283633B1 (fr)
NO (1) NO322266B1 (fr)
PL (1) PL185778B1 (fr)
PT (1) PT901492E (fr)
RU (1) RU2168513C2 (fr)
SK (1) SK282471B6 (fr)
WO (1) WO1997043291A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003026673A (ja) * 1999-03-05 2003-01-29 Asahi Kasei Corp 骨形成促進剤
EP1229934B1 (fr) 1999-10-01 2014-03-05 Immunogen, Inc. Compositions et methodes de traitement du cancer utilisant des immunoconjugues et des agents chimiotherapeutiques
ITMI20012185A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato
ITMI20012186A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14-beta-idrossi-baccatina iii-1,14-carbonato
WO2006122408A1 (fr) 2005-05-18 2006-11-23 Aegera Therapeutics Inc. Composes liants de domaine bir
JP5419685B2 (ja) 2006-05-16 2014-02-19 ファーマサイエンス・インコーポレイテッド Ｉａｐｂｉｒドメイン結合タンパク質
EP2080764B1 (fr) 2008-01-18 2012-08-22 INDENA S.p.A. Formes solides d'ortataxel
EP2534170B1 (fr) 2010-02-12 2017-04-19 Pharmascience Inc. Composés de liaison au domaine iap bir
CN113603660B (zh) * 2021-09-02 2024-01-05 无锡紫杉药业有限公司 一种10-羰基多西他赛的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601785B1 (fr) * 1986-07-15 1989-07-28 Telecommunications Sa Dispositif de reserve pour cable a fibre optique et le procede de mise en oeuvre
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5393886A (en) * 1993-05-05 1995-02-28 The Du Pont Merck Pharmaceutical Company Intermediates for the synthesis of anthrapyrazolone anticancer agents
IT1275936B1 (it) * 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
IT1275435B (it) * 1995-05-19 1997-08-07 Indena Spa Derivati della 10-desacetil-14beta-idrossibaccatina iii,loro metodo di preparazione e formulazioni che li contengono

Also Published As

Publication number Publication date
HUP9903649A2 (hu) 2001-05-28
CZ287489B6 (en) 2000-12-13
ITMI960942A0 (fr) 1996-05-10
DE69714040T2 (de) 2003-03-13
ITMI960942A1 (it) 1997-11-10
NO322266B1 (no) 2006-09-04
US5955489A (en) 1999-09-21
AU2888697A (en) 1997-12-05
IT1283633B1 (it) 1998-04-23
PL185778B1 (pl) 2003-07-31
WO1997043291A1 (fr) 1997-11-20
KR100314382B1 (ko) 2002-02-28
JP3423002B2 (ja) 2003-07-07
AU715748B2 (en) 2000-02-10
EP0901492A1 (fr) 1999-03-17
NO985187D0 (no) 1998-11-06
CN1218475A (zh) 1999-06-02
JP2000513716A (ja) 2000-10-17
ATE220680T1 (de) 2002-08-15
SK282471B6 (sk) 2002-02-05
KR20000010894A (ko) 2000-02-25
ES2180985T3 (es) 2003-02-16
DK0901492T3 (da) 2002-09-02
EP0901492B1 (fr) 2002-07-17
CA2253912A1 (fr) 1997-11-20
CA2253912C (fr) 2006-03-28
PT901492E (pt) 2002-10-31
HU224965B1 (en) 2006-04-28
CN1097055C (zh) 2002-12-25
SK153998A3 (en) 1999-04-13
PL329768A1 (en) 1999-04-12
NO985187L (no) 1998-11-06
DE69714040D1 (de) 2002-08-22
CZ361998A3 (cs) 1999-06-16
RU2168513C2 (ru) 2001-06-10
HUP9903649A3 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
HU9303666D0 (en) Azanorbornane derivatives
HU9500836D0 (en) Fluoroalkoxybenzyl derivatives of nitrogen containing heterocycles
GR3033846T3 (en) Imidazopyridines and their use in treating gastrointestinal diseases.
HK1019603A1 (en) Taxane derivatives, the preparation thereof and formulations containing them
ZA948589B (en) Phenylindole compounds
ZA911211B (en) New beta-phenylisoserine derivative,and its preparation and use
ZA9429B (en) Pyrrolidine derivatives their preparation and medicaments containing them
IL107520A0 (en) Substituted ortho-ethenylphenylacetic acid derivatives and pharmaceutical compositions containing them
HUT73231A (en) Pharmaceutical compositions with 17-beta-monosubstituted-carbamoyl-4-aza-5-alpha-androst-1-en-3-ones for treatment of chronic prostatitis
EP0667850A1 (fr) Acides tartroniques, leurs ethers acetaliques et o-esters.
ZA9480B (en) Pyrrolidine derivatives their preparation and medicaments containing them
GR3025050T3 (en) Etoposide derivatives, process for their preparation, their use as a drug and in the preparation of a drug for treating cancer.
PT918754E (pt) Derivados de diamidas de ácido antranílico, sua preparação e utilização farmacêutica como agentes anti-gastrina
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140429